Solventum Corporation (SOLV) Actualités

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form 8-K - Current report

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance PR Newswire ST...

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City PR Newswire ST. PAUL, Minn., Feb...

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns...

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for...

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing...

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition:...

Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025

Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025 PR Newswire ST...

Trian Issues Open Letter to Solventum Shareholders

Despite Performance Declines Since Spinning Out of 3M, Trian Believes Solventum Has Potential to Drive...

The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing

The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes...

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement